Craft

JETEMA

Stock Price

₩19.4 K

2024-10-29

Market Capitalization

₩346.5 B

2024-10-29

Revenue

₩58.7 B

FY, 2023

JETEMA Summary

Company Summary

Overview
JETEMA (제테마, formerly known as Pronexx) is a company that specializes in the research and development of medicines and medical devices. It develops botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skincare hyaluronic acid masks.
Type
Public
Status
Active
Founded
2009
HQ
Weonju, KR | view all locations
Website
http://www.jetema.com
Cybersecurity rating
Sectors

Key People

  • Kim Jaeyoung, President

    LocationsView all

    4 locations detected

    • Weonju, Gangwon-do HQ

      Korea (Republic of)

      1283-4, Gagok-ri, Jijeong-myeon

    • Yongin-si, Gyeonggi-do

      Korea (Republic of)

      #502, Daewoo Frontier Valley 1, 16-25, Dongbaekjungang-ro, 16beon-gi, Giheung-gu

    • Seoul

      Korea (Republic of)

      6-14 Bongeunsa-ro 68-gil, Samseong-dong, Gangnam-gu

    • Rayong, จ.ระยอง

      Thailand

      300/69 Moo1 T.Tasit A.Pluakdaeng

    JETEMA Financials

    Summary Financials

    Revenue (FY, 2023)
    ₩58.7B
    Gross profit (FY, 2023)
    ₩36.4B
    Net income (FY, 2023)
    ₩13.6B
    Cash (FY, 2023)
    ₩46.2B
    EBIT (FY, 2023)
    (₩382.7M)
    Enterprise value
    $430.7B

    Footer menu